Skip to main content
HCPCS J2305 · Level II · Part B drug

J2305: nitroglycerin, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J2305

Billing unit
5 MG
Inj, nitroglycerin, 5 mg
ASP payment limit
$1.542
October 2026; -1.0% vs July 2026
Practitioner MUE
none published
CMS publishes no MUE for this code
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J2305 is the Level II code for Injection, nitroglycerin, 5 mg, billed per 5 MG. The Medicare Part B ASP payment limit for October 2026 is $1.542 per billing unit, down 1.0% from July 2026. Under OPPS it carries status indicator N. J2305 is billed in units of 5 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 6 NDCs to it, sold as Nitroglycerin In D5W, Nitroglycerin by Baxter Healthcare Corporation, Henry Schein Inc., American Regent, Inc. No current Billing and Coding Article lists J2305, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J2305 at $1.542 per 5 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $1.557 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J2305
QuarterPayment limitPerCoinsurance
October 2026$1.5425 MG20%
July 2026$1.5575 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 6 NDCs from 4 labelers to J2305. Report the NDC in the claim's drug segment and bill the number of J2305 units that equals the quantity administered divided by 5 MG; the last column gives units per full package.

NDCs that crosswalk to J2305
NDCDrug nameLabelerPackage sizeBilling units / package
00338-1047-02Nitroglycerin In D5WBaxter Healthcare Corporation250 × 1260
00338-1049-02Nitroglycerin In D5WBaxter Healthcare Corporation250 × 12120
00338-1051-02Nitroglycerin In D5WBaxter Healthcare Corporation250 × 12240
00404-9928-10NitroglycerinHenry Schein Inc.10 × 110
00517-4810-25NitroglycerinAmerican Regent, Inc.10 × 25250
51662-1386-01NitroglycerinHF Acquisition Co. LLC, DBA HealthFirst10 × 110

Medically Unlikely Edits (MUE)

CMS does not publish an MUE for J2305 in the 2026 Q4 tables. Some MUE values are confidential and applied without publication, so unit limits can still deny; document the dose and the units calculation on every claim.

MUE for J2305 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J2305 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J2305 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J2305 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J2305 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J2305 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J2305 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J2305 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J2305

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J2305

What does HCPCS code J2305 describe?

J2305 is defined by CMS as "Injection, nitroglycerin, 5 mg". Each billing unit represents 5 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J2305 a CPT code?

No. J2305 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as nitroglycerin; CPT codes are five-character codes maintained by the AMA. On a Part B claim J2305 reports the drug itself in 5 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J2305 in October 2026?

The ASP-based payment limit is $1.542 per 5 MG, with 20% beneficiary coinsurance. The July 2026 limit was $1.557. Commercial payers use their own fee schedules.

Which NDCs map to J2305?

The October 2026 ASP crosswalk lists 6 NDCs from 4 labelers: Nitroglycerin In D5W (Baxter Healthcare Corporation); Nitroglycerin (Henry Schein Inc.); Nitroglycerin (American Regent, Inc.); Nitroglycerin (HF Acquisition Co. LLC, DBA HealthFirst). For example NDC 00338-1047-02 (package size 250) equals 60 billing units of J2305.

Does J2305 have NCCI bundling edits?

No active practitioner PTP pairs list J2305 as a column-1 or column-2 code in the v323r0 release.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.